{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:41:54Z","timestamp":1773924114245,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3142-5","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T07:29:57Z","timestamp":1526887797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9294","authenticated-orcid":false,"given":"Dorcas","family":"Obiri-Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faustina","family":"Pappoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hayfron-Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Essien-Baidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin","family":"Kwakye-Nuako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Ayisi Addo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"3142_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2334-6-59","volume":"6","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, et al. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis. 2006;6:59.","journal-title":"BMC Infect Dis"},{"key":"3142_CR2","volume-title":"Global AIDs Update 2016","author":"UNAIDS","year":"2016","unstructured":"UNAIDS, Global AIDs Update 2016. 2016."},{"key":"3142_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","volume":"8","author":"KK Vidya Vijayan","year":"2017","unstructured":"Vidya Vijayan KK, et al. Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections. Front Immunol. 2017;8:580.","journal-title":"Front Immunol"},{"issue":"1","key":"3142_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12879-017-2473-y","volume":"17","author":"RO da Silva Escada","year":"2017","unstructured":"da Silva Escada RO, et al. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death. BMC Infect Dis. 2017;17(1):373.","journal-title":"BMC Infect Dis"},{"key":"3142_CR5","unstructured":"UNAIDS, Global HIV\/AIDS statistics. 2017: Fact Sheets."},{"key":"3142_CR6","volume-title":"In Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","author":"WHO","year":"2013","unstructured":"WHO. In Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva: Recommendations for a Public Health Approach; 2013."},{"key":"3142_CR7","unstructured":"Guidelines for antiretroviral therapy in Ghana (2016). Ghana Health Service\/National AIDS\/STI Control Programme: Accra."},{"issue":"3","key":"3142_CR8","doi-asserted-by":"publisher","first-page":"e0122583","DOI":"10.1371\/journal.pone.0122583","volume":"10","author":"A Asfaw","year":"2015","unstructured":"Asfaw A, et al. CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, northern Ethiopia: a retrospective cross-sectional study. PLoS One. 2015;10(3):e0122583.","journal-title":"PLoS One"},{"issue":"6","key":"3142_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/597093","volume":"48","author":"CF Kelley","year":"2009","unstructured":"Kelley CF, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48(6):787\u201394.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3142_CR10","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1086\/425075","volume":"190","author":"CJ Smith","year":"2004","unstructured":"Smith CJ, et al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. J Infect Dis. 2004;190(10):1860\u20138.","journal-title":"J Infect Dis"},{"issue":"3","key":"3142_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1086\/510746","volume":"44","author":"RD Moore","year":"2007","unstructured":"Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44(3):441\u20136.","journal-title":"Clin Infect Dis"},{"key":"3142_CR12","doi-asserted-by":"publisher","first-page":"32947","DOI":"10.1038\/srep32947","volume":"6","author":"M Hoenigl","year":"2016","unstructured":"Hoenigl M, et al. Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Sci Rep. 2016;6:32947.","journal-title":"Sci Rep"},{"key":"3142_CR13","unstructured":"Ghana AIDS Commission. Ghana National HIV and AIDS Strategic Plan 2016-2020. Accra: GAC; 2016."},{"issue":"1","key":"3142_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12879-016-1402-9","volume":"16","author":"O Kukoyi","year":"2016","unstructured":"Kukoyi O, et al. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana. BMC Infect Dis. 2016;16(1):58.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3142_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jac\/dkt336","volume":"69","author":"FS Sarfo","year":"2014","unstructured":"Sarfo FS, et al. Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana. J Antimicrob Chemother. 2014;69(1):254\u201361.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3142_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"9731","key":"3142_CR17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","volume":"375","author":"D Donnell","year":"2010","unstructured":"Donnell D, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092\u20138.","journal-title":"Lancet"},{"key":"3142_CR18","first-page":"6","volume":"2016","author":"F Wudineh","year":"2016","unstructured":"Wudineh F, Damtew B. Mother-to-child transmission of HIV infection and its determinants among exposed infants on care and follow-up in Dire Dawa City, Eastern Ethiopia. AIDS Res Treat. 2016;2016:6.","journal-title":"AIDS Res Treat"},{"key":"3142_CR19","volume-title":"\"90\u201390-90\"; an ambitious treatment target to help end the AIDS epidemic","author":"UNAIDS","year":"2014","unstructured":"UNAIDS, \"90\u201390-90\"; an ambitious treatment target to help end the AIDS epidemic. 2014."},{"key":"3142_CR20","unstructured":"WHO. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy.Licence: Cc by-NC-SA 3.0 IGO. Geneva: WHO; 2017."},{"issue":"10","key":"3142_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S2222-1808(16)61127-1","volume":"6","author":"G Kwakye-Nuako","year":"2016","unstructured":"Kwakye-Nuako G, et al. Modulation of cyptosporidiosis by CD4 levels in chronic diarrhoea HIV\/AIDS individuals visiting Tarkwa municipal hospital, Ghana. Asian Pacific Journal of Tropical Disease. 2016;6(10):770\u20135.","journal-title":"Asian Pacific Journal of Tropical Disease"},{"issue":"1","key":"3142_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/1471-2334-11-306","volume":"11","author":"JAS Casotti","year":"2011","unstructured":"Casotti JAS, et al. Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study. BMC Infect Dis. 2011;11(1):306.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"3142_CR23","doi-asserted-by":"publisher","first-page":"e0156099","DOI":"10.1371\/journal.pone.0156099","volume":"11","author":"C Kelly","year":"2016","unstructured":"Kelly C, et al. Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes. PLoS One. 2016;11(6):e0156099.","journal-title":"PLoS One"},{"issue":"1","key":"3142_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13104-016-2182-4","volume":"9","author":"LD Gezie","year":"2016","unstructured":"Gezie LD. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot referral hospital, Northwest Ethiopia: multilevel analysis. BMC Research Notes. 2016;9(1):377.","journal-title":"BMC Research Notes"},{"issue":"10","key":"3142_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/aid.2014.0046","volume":"30","author":"MJ Vinikoor","year":"2014","unstructured":"Vinikoor MJ, et al. Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia. AIDS Res Hum Retrovir. 2014;30(10):949\u201355.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"3142_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/archinte.167.7.684","volume":"167","author":"MJ Silverberg","year":"2007","unstructured":"Silverberg MJ, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167(7):684\u201391.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"3142_CR27","doi-asserted-by":"publisher","first-page":"S432","DOI":"10.1093\/ofid\/ofx163.1093","volume":"4","author":"AR Vega","year":"2017","unstructured":"Vega AR, et al. Gender differences in Virologic response after antiretroviral therapy in treatment-na\u00efve HIV-infected individuals: results from the 550 clinic HIV cohort study. Open Forum Infectious Diseases. 2017;4(Suppl 1):S432\u20133.","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"3142_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2334-12-293","volume":"12","author":"K Thorsteinsson","year":"2012","unstructured":"Thorsteinsson K, et al. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study. BMC Infect Dis. 2012;12(1):293.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"3142_CR29","doi-asserted-by":"publisher","first-page":"e83649","DOI":"10.1371\/journal.pone.0083649","volume":"8","author":"A Cescon","year":"2014","unstructured":"Cescon A, et al. Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study. PLoS One. 2014;8(12):e83649.","journal-title":"PLoS One"},{"issue":"1","key":"3142_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/1471-2458-13-617","volume":"13","author":"V Hansana","year":"2013","unstructured":"Hansana V, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13(1):617.","journal-title":"BMC Public Health"},{"key":"3142_CR31","doi-asserted-by":"crossref","unstructured":"Obiri-Yeboah D, et al. The \u2018fears\u2019 of disclosing HIV status to sexual partners: a mixed methods study in a counseling setting in Ghana. AIDS Behav. 2016;","DOI":"10.1007\/s10461-015-1022-1"},{"issue":"1","key":"3142_CR32","doi-asserted-by":"publisher","first-page":"e53586","DOI":"10.1371\/journal.pone.0053586","volume":"8","author":"B Elul","year":"2013","unstructured":"Elul B, et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One. 2013;8(1):e53586.","journal-title":"PLoS One"},{"issue":"1","key":"3142_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/QAI.0000000000000712","volume":"70","author":"AA Zwerling","year":"2015","unstructured":"Zwerling AA, et al. Screening for tuberculosis among adults newly diagnosed with hiv in sub-saharan africa: a cost-effectiveness analysis. J Acquir Immune Defic Syndr. 2015;70(1):83\u201390.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3142_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/01.aids.0000434936.57880.cd","volume":"28","author":"HM Soeters","year":"2014","unstructured":"Soeters HM, et al. The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review. AIDS. 2014;28(2):245\u201355.","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3142-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3142-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3142-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T19:05:49Z","timestamp":1558379149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3142-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3142"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3142-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the University of Cape-Coast (IRB-UCC) Cape Coast, Ghana. Permission to undertake the study at the HIV Clinics of the hospital was sought and granted by the hospital management. The participants enrolled in the study gave written informed consent after full explanation of the procedure in the language and\/or dialect they best understand.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"230"}}